“Whoa! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Incretins, diabetes, and bariatric surgery: a review

The prevalence of type 2 diabetes mellitus is increasing rapidly in the United States, with almost 16 million adults currently affected [1] . Obesity is an independent risk factor for diabetes. Among diabetic individuals, 50% are obese, with a body mass index (BMI) > 30 kg/m 2 [1] . Bariatric surgery (surgical weight loss) has become an effective treatment for morbid obesity in those patients who have failed medical management of their illness. Up to 30% of patients presenting for bariatric surgery have type 2 diabetes mellitus [2,3] . The most commonly performed surgical procedure for weight loss, the Roux-en- Y gastric bypass (GBP), results in a percentage of excess weight loss (%EWL) of 50% to 75% and “cures” diabetes in 70% to 100% of patients [2,4] by improving both insulin secretion and sensitivity [5] . The possible role of the gut hormones known as incretins in the improvement of diabetes after bariatric surgery has been hypothesized. The incretins, gut peptides secreted in response to meals, enhance insulin secretion. The impaired incretin secretion in obese type 2 diabetes mellitus is partially responsible for the defect in insulin secretion [6–9] . In this article we review the role of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Surgery for Obesity and Related Diseases Elsevier
Loading next page...

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.